- Home
- / 22nd Century Group
22nd Century Group
Stock Price
$0.1
2024-10-29
Market Capitalization
$3.3 M
2024-10-29
Revenue
$17.6 M
FY, 2025
22nd Century Group Summary
Company Summary
- Overview
- 22nd Century Group is a plant biotechnology company developing tobacco harm reduction and smoking cessation products. Its technology also allows the levels of cannabinoids to be decreased or increased in the cannabis plant.
- Type
- Public
- Status
- Active
- Founded
- 1998
- HQ
- Buffalo, NY, US | view all locations
- Website
- http://www.xxiicentury.com
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Juan Sanchez Tamburrino, Vice President of Research and Development
John Franzino, Chief Administrative Officer
Michael Koganov, Director
Operating MetricsView all
Research Cigarettes Produced to Date
28M
FY, 2019
Manufacturing Facilities
1
FY, 2019
LocationsView all
2 locations detected
Buffalo, NY HQ
United States
500 Seneca St Suite 507
Williamsville, NY
United States
8560 Main St #4
22nd Century Group Financials
Summary Financials
- Revenue (Q1, 2026)
- $4.1M
- Gross profit (Q1, 2026)
- $2.2M
- Net income (Q1, 2026)
- ($3.3M)
- Cash (Q1, 2026)
- $9.5M
- EBIT (Q1, 2026)
- ($3.0M)
- Enterprise value
- ($5.1M)